Application Sponsors
NDA 018605 | PHARMACIA AND UPJOHN | |
Marketing Status
Application Products
001 | SUSPENSION;ORAL | 250MG/5ML | 0 | AZULFIDINE | SULFASALAZINE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1980-12-29 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 1981-07-21 | |
LABELING; Labeling | SUPPL | 6 | AP | 1985-02-05 | |
LABELING; Labeling | SUPPL | 9 | AP | 1983-12-19 | |
LABELING; Labeling | SUPPL | 10 | AP | 1990-07-18 | |
CDER Filings
PHARMACIA AND UPJOHN
cder:Array
(
[0] => Array
(
[ApplNo] => 18605
[companyName] => PHARMACIA AND UPJOHN
[docInserts] => ["",""]
[products] => [{"drugName":"AZULFIDINE","activeIngredients":"SULFASALAZINE","strength":"250MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AZULFIDINE","submission":"SULFASALAZINE","actionType":"250MG\/5ML","submissionClassification":"SUSPENSION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)